Skip to main content
FinSpry Logo
FinSpry
XGN logo
XGN
(NASDAQ)
Exagen Inc.
$3.06-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Exagen (XGN) Stock Price & Financial Analysis

Exagen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.91 - $3.09
52-Week High$12.23
52-Week Low$2.59
Open$2.93
Volume105.53K
Average Volume (3M)105.53K
Market Cap65.97M
Shares Outstanding21.56M
Price to Sales (P/S)0.97
Price to Book (P/B)3.72
EV/EBITDA-2.42
Revenue (TTM)66.58M
Net Income (TTM)-19.95M
Free Cash Flow (TTM)-14.27M
EPS (TTM)$-0.93
Profit Margin-29.97%
Operating Margin-21.13%
Return on Equity (ROE)-114.34%
Debt to Equity0.31
50-Day MA$3.44
200-Day MA$7.30
52-Week Change-23.41%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Exagen

What is the current stock price for XGN?

As of the latest trading session, XGN stock trades at $3.06. The 52-week range is $2.59–$12.23, with a day range of $2.91–$3.08.

What is the P/E ratio for XGN?

The P/E ratio (Price-to-Earnings) for XGN is shown in the Key Statistics section. This valuation metric helps compare Exagen Inc. to industry peers.

Does XGN pay dividends?

Exagen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XGN?

Based on 6 analysts, the consensus for XGN is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of XGN?

Exagen's market capitalization is $66.0M, classifying it as a micro-cap company. Exagen operates in the Healthcare sector within the Diagnostics & Research industry.